These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3778479)

  • 1. Evidence for direct binding of Clostridium botulinum type E derivative toxin and its fragments to gangliosides and free fatty acids.
    Kamata Y; Kozaki S; Sakaguchi G; Iwamori M; Nagai Y
    Biochem Biophys Res Commun; 1986 Nov; 140(3):1015-9. PubMed ID: 3778479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLC immunostaining characterization of Clostridium botulinum type A neurotoxin binding to gangliosides and free fatty acids.
    Takamizawa K; Iwamori M; Kozaki S; Sakaguchi G; Tanaka R; Takayama H; Nagai Y
    FEBS Lett; 1986 Jun; 201(2):229-32. PubMed ID: 3709810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of the ganglioside-binding fragment of Clostridium botulinum type E neurotoxin.
    Kamata Y; Kimura Y; Hiroi T; Sakaguchi G; Kozaki S
    Biochim Biophys Acta; 1993 Feb; 1156(2):213-8. PubMed ID: 8427878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic structure of Clostridium botulinum type B neurotoxin and its interaction with gangliosides, cerebroside, and free fatty acids.
    Kozaki S; Ogasawara J; Shimote Y; Kamata Y; Sakaguchi G
    Infect Immun; 1987 Dec; 55(12):3051-6. PubMed ID: 2824382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a.
    Nishiki T; Tokuyama Y; Kamata Y; Nemoto Y; Yoshida A; Sato K; Sekiguchi M; Takahashi M; Kozaki S
    FEBS Lett; 1996 Jan; 378(3):253-7. PubMed ID: 8557112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of Clostridium botulinum neurotoxin to gangliosides.
    Ochanda JO; Syuto B; Ohishi I; Naiki M; Kubo S
    J Biochem; 1986 Jul; 100(1):27-33. PubMed ID: 3759936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins.
    Kozaki S; Kamata Y; Watarai S; Nishiki T; Mochida S
    Microb Pathog; 1998 Aug; 25(2):91-9. PubMed ID: 9712688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of botulinum and tetanus neurotoxins to ganglioside GT1b and derivatives thereof.
    Schengrund CL; DasGupta BR; Ringler NJ
    J Neurochem; 1991 Sep; 57(3):1024-32. PubMed ID: 1861141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential contribution of the residues in C-terminal half of the heavy chain of botulinum neurotoxin type B to its binding to the ganglioside GT1b and the synaptotagmin 2/GT1b complex.
    Kohda T; Ihara H; Seto Y; Tsutsuki H; Mukamoto M; Kozaki S
    Microb Pathog; 2007; 42(2-3):72-9. PubMed ID: 17188834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptotagmin II and gangliosides bind independently with botulinum neurotoxin B but each restrains the other.
    Atassi MZ; Taruishi M; Naqvi M; Steward LE; Aoki KR
    Protein J; 2014 Jun; 33(3):278-88. PubMed ID: 24740609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity.
    Shone CC; Hambleton P; Melling J
    Eur J Biochem; 1985 Aug; 151(1):75-82. PubMed ID: 3896784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.
    Ayyar BV; Aoki KR; Atassi MZ
    Infect Immun; 2015 Apr; 83(4):1465-76. PubMed ID: 25624352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of Ganglioside Receptor Recognition by Botulinum Neurotoxin Serotype E.
    Masuyer G; Davies JR; Stenmark P
    Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the receptor-binding sites in the carboxyl-terminal half of the heavy chain of botulinum neurotoxin types C and D.
    Tsukamoto K; Kozai Y; Ihara H; Kohda T; Mukamoto M; Tsuji T; Kozaki S
    Microb Pathog; 2008 Jun; 44(6):484-93. PubMed ID: 18242046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin.
    Kozaki S; Kamata Y; Nagai T; Ogasawara J; Sakaguchi G
    Infect Immun; 1986 Jun; 52(3):786-91. PubMed ID: 2423459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between Clostridium botulinum neurotoxin and gangliosides.
    Kitamura M; Iwamori M; Nagai Y
    Biochim Biophys Acta; 1980 Mar; 628(3):328-35. PubMed ID: 6768400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a binding site for ganglioside on the receptor binding domain of tetanus toxin.
    Louch HA; Buczko ES; Woody MA; Venable RM; Vann WF
    Biochemistry; 2002 Nov; 41(46):13644-52. PubMed ID: 12427026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different response of the knockout mice lacking b-series gangliosides against botulinum and tetanus toxins.
    Kitamura M; Igimi S; Furukawa K; Furukawa K
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):1-3. PubMed ID: 15919183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of a protease-sensitive acceptor component in mouse brain synaptosomes for Clostridium botulinum type B neurotoxin.
    Ogasawara J; Kamata Y; Sakaguchi G; Kozaki S
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):351-5. PubMed ID: 2060767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological characterization of papain-induced fragments of Clostridium botulinum type A neurotoxin and interaction of the fragments with brain synaptosomes.
    Kozaki S; Miki A; Kamata Y; Ogasawara J; Sakaguchi G
    Infect Immun; 1989 Sep; 57(9):2634-9. PubMed ID: 2668181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.